Zhan et al. showed that UC-MSC-CM significantly decreased tau phosphorylated at the Thr181 level, which increased in AD-alleviated intracellular and mitochondrial oxidative stress of okadaic acid (OA)-treated SH-SY5Y cells. Here, MAPT is linked to Alzheimer disease.